News

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
When I was assigned to write my first story about the blockbuster weight loss drug Ozempic in 2023, I groaned. Yes, weight ...
One year ago, we recommended buying ResMed stock after concerns that weight loss drugs would hurt demand for its sleep apnea ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
Real success is about taking control, gaining confidence, and achieving the energy to live life to the full, not simply shedding kilos.
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
More than 40% of American's are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic ...
Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...
GLP-1s double as not only a weight loss drug but also a dating confidence booster. Fifty-nine percent of surveyed GLP-1 users ...
Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP-1 RAs.
NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new ...